K-Dur Reverse Payment Legal: Special Master
By Jesse Greenspan ( February 5, 2009, 12:00 AM EST) -- A special master has recommended that the U.S. District Court for the District of New Jersey dismiss a class action that accuses Schering-Plough Corp. and Upsher-Smith Laboratories Inc. of conspiring to keep generic versions of heart drug K-Dur 20 off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.